Stryker Corporation

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-05-21 pm EDT			5-day change	1st Jan Change
330.5 ^USD	+0.24%		+1.91%	+10.37%

May. 16	Stryker Insider Sold Shares Worth $3,276,516, According to a Recent SEC Filing	MT
May. 16	Everlasting momentum

Stryker to participate in Citi's 2024 Unplugged Medtech and Life Sciences Access Day

February 06, 2024 at 08:31 am EST

Michigan - Stryker (NYSE: SYK) will participate in Citi's 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at Citigroup Headquarters, New York, New York.

Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will represent the Company in a presentation scheduled for 1:45 p.m. Eastern Time.

A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site.

About Stryker

Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually.

Contact:

Jason Beach

Tel: 269-385-2600

Email: jason.beach@stryker.com

Yin Becker

Tel: 269-385-2600

Email: yin.becker@stryker.com

Latest news about Stryker Corporation

Stryker Insider Sold Shares Worth $3,276,516, According to a Recent SEC Filing	May. 16	MT
Everlasting momentum	May. 16
ANALYST RECOMMENDATIONS : Ecolab, Texas Instruments, Cisco, Britvic, Shopify...	May. 16
Stryker Keeps Quarterly Dividend at $0.80 a Share, Payable July 31 to Shareholders of Record on June 28	May. 09	MT
Stryker Corporation Declares Quarterly Dividend, Payable on July 31, 2024	May. 09	CI
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices	May. 02	RE
UBS Adjusts Stryker Price Target to $351 From $339, Maintains Neutral Rating	May. 01	MT
BTIG Adjusts Price Target on Stryker to $369 From $366	May. 01	MT
Piper Sandler Adjusts Price Target on Stryker to $380 From $375	May. 01	MT
Baird Adjusts Price Target on Stryker to $378 From $367	May. 01	MT
Stifel Adjusts Price Target on Stryker to $375 From $350	May. 01	MT
Oppenheimer Adjusts Price Target on Stryker to $360 From $350	May. 01	MT
Roth MKM Adjusts Price Target on Stryker to $405 From $348	May. 01	MT
Jefferies Adjusts Price Target on Stryker to $400 From $390, Keeps Buy Rating	May. 01	MT
Bernstein Adjusts Price Target on Stryker to $393 From $385, Keeps Outperform Rating	May. 01	MT
Nephron Research Raises Stryker's Price Target to $400 From $385	May. 01	MT
Barclays Raises Stryker's Price Target to $376 From $372	May. 01	MT
Wells Fargo Adjusts Price Target on Stryker to $381 From $364	May. 01	MT
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants	Apr. 30	RE
Stryker's Q1 Adjusted EPS, Sales Increase; 2024 EPS Guidance Boosted; Shares Drop After Hours	Apr. 30	MT
Stryker Guides For 2024 EPS of $11.85-$12.05 on Sales Growth of 8.5%-9.5%, vs CIQ Analyst Consensus of $11.85/Share on Sales of $22.1 Billion	Apr. 30	MT
Earnings Flash (SYK) STRYKER CORPORATION Reports Q1 Revenue $5.24B, vs. Street Est of $5.11B	Apr. 30	MT
Stryker Lifts Organic Sales Outlook After 1Q Rise	Apr. 30	DJ
Transcript : Stryker Corporation, Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Stryker Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI

Chart Stryker Corporation

Duration

Period

More charts

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-27 - Ex-dividend day

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Stryker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

330.5 USD

Average target price

372.4 USD

Spread / Average Target

+12.66%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+10.37%	126B
SMITH & NEPHEW PLC	-5.47%	11.33B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.83%	9.27B
GLAUKOS CORPORATION	+36.53%	5.5B
INSPIRE MEDICAL SYSTEMS, INC.	-25.10%	4.61B
AXONICS, INC.	+8.61%	3.45B
ENOVIS CORPORATION	-10.05%	2.81B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-10.99%	2.09B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.20%	2.08B
DOUBLE MEDICAL TECHNOLOGY INC.	-23.65%	1.78B

Medical Devices & Implants